These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8814671)

  • 21. Trough: peak ratio: clinically useful or practically irrelevant?
    Elliott HL; Meredith PA
    J Hypertens; 1995 Mar; 13(3):279-83. PubMed ID: 7622847
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical benefits of a consistent reduction in blood pressure.
    Mancia G; Cattaneo BM; Omboni S; Grassi G
    J Hypertens Suppl; 1998 Oct; 16(6):S35-9. PubMed ID: 9856382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five decades of antihypertensive treatment: the unresolved issues.
    Julius S
    J Hypertens Suppl; 2000 Jul; 18(3):S3-7. PubMed ID: 10952081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension. New French recommendations].
    Milon H; Mestre C; Lantelme P
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1479-86. PubMed ID: 11190299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine for hypertension.
    Drug Ther Bull; 1997 May; 35(5):33-6. PubMed ID: 9282418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trough-to-peak ratio and 24-hour blood pressure control. Methodologic issues.
    Myers MG
    Am J Hypertens; 1995 Feb; 8(2):214-9. PubMed ID: 7755954
    [No Abstract]   [Full Text] [Related]  

  • 27. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Valley/peak ratio and pressure changes during treatment with fosinopril in hypertensive elderly patients].
    Cicconetti P; Salza MC; Rizzo V; Bianchi A; Capponi L; Marigliano V
    Clin Ter; 1996; 147(7-8):359-64. PubMed ID: 9118617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Threshold and target blood pressures for treating hypertension. The facts].
    Holzgreve H
    MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic implications of the new JNC 7 blood pressure guidelines.
    Capriotti T
    Medsurg Nurs; 2003 Oct; 12(5):325-30. PubMed ID: 14608690
    [No Abstract]   [Full Text] [Related]  

  • 31. Implications and controversies of recent hypertension trials.
    Schwartz ML
    J Am Coll Cardiol; 2006 Aug; 48(4):848-9; author reply 849-50. PubMed ID: 16904567
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Target blood pressure values from the cardiologic viewpoint].
    Klein W
    Wien Med Wochenschr; 1999; 149(23-24):625-8. PubMed ID: 10721157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of blood pressure variability: a new strategy for the treatment of hypertension.
    Su DF; Miao CY
    Trends Pharmacol Sci; 2005 Aug; 26(8):388-90. PubMed ID: 15990175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of the recent clinical trials in hypertension.
    Moser M
    N Y State J Med; 1987 Jan; 87(1):5-6. PubMed ID: 3550545
    [No Abstract]   [Full Text] [Related]  

  • 37. Concentration-effect relationships and implications for trough-to-peak ratio.
    Meredith PA; Elliott HL
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):66S-70S; discussion 87S-90S. PubMed ID: 8896666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial hypertension 1976. Present point of view for medical management. Part 1].
    Lohmann FW
    Ther Ggw; 1976 Jan; 115(1):20-36. PubMed ID: 1257915
    [No Abstract]   [Full Text] [Related]  

  • 39. Suggested guidelines for determining the trough-to-peak ratio of antihypertensive drugs.
    Myers MG
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):76S-82S; discussion 87S-90S. PubMed ID: 8896668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Pressure Targets: Will We Reach Definite Figures? I Currently Have Mine.
    Jardim PCBV
    Arq Bras Cardiol; 2017 Jul; 109(1):1-4. PubMed ID: 28767883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.